myLaminin News

Security and trust are not one-time achievements, they are continuous commitments that shape how we build and operate our platform.

We are proud to share that myLaminin has successfully completed its annual SOC 2 Type II audit, receiving an unqualified opinion with no exceptions noted.

This independent audit provides validation of the design and operational effectiveness of our controls, including the security, availability, and reliability of our platform supporting research data management and clinical trial workflows.

This milestone marks another consecutive year of SOC 2 Type II compliance, continuing a track record we have maintained since our first audit in 2022.

For research institutions, academic organizations, and clinical research teams that rely on myLaminin to manage sensitive data and intellectual property, this achievement reinforces our ongoing commitment to:
Secure research data management
Regulatory and compliance alignment
Protection of sensitive and high-value research information
Operational reliability in research and clinical environments
As research ecosystems continue to evolve and data governance requirements become increasingly complex, maintaining independently validated security standards remains central to our mission.

Most importantly, this achievement reflects the dedication of the entire myLaminin team. Their continued focus on building and maintaining a secure, reliable platform ensures researchers can work with confidence every day.

We look forward to continuing to strengthen our platform and supporting the research and clinical communities we serve.